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Developmental Model of Substance Abuse  
Van Hout M-C, Norman, I J, Rich E & Bergin M
ABSTRACT 
Background 
Misuse of codeine containing medicines is an emerging public health issue. 
Aims 
We present the application of Liese and Franz’s (1996) cognitive developmental model of 
substance abuse to the trajectory from legitimate codeine use for pain, toward that of 
therapeutic and other forms of misuse, and physical and psychological dependence. It 
illustrates a cognitive behavioural analysis of the experiences of codeine misusers – which 
‘surfaces’ the specific beliefs, thoughts, emotions and behaviours of this group of hidden 
codeine dependent individuals, who are distinct and unique from other opioid dependent 
cohorts. 
Methods: 
In-depth one-to-one interviews with codeine misusers and dependent individuals in Ireland 
(n=21), and South Africa (n=25) are analysed and applied to Liese and Franz’s (1996) 
cognitive developmental model of substance abuse. 
Results 
Misuse and dependence pathways are maintained by the interplay between physiological 
determinants relating to pain, withdrawal and tolerance, and psychological influences such as 
therapeutic need, pre-empting of anticipated physical pain, pleasure from the dreamy sedative 
opiate effect of codeine and relief of emotional distress. Progression toward habitual use and 
misuse for therapeutic and intoxication purposes appears mediated by external environmental 
triggers pertaining to availability, internal meta-cognitions around physical pain and 
emotional distress, and increasing  importance of codeine in the life of the user. 
Conclusion 
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The concept mapping of codeine misuse and dependence presented here could provide 
psychological therapists working with individuals experiencing problems with codeine, 
misusing codeine and those with iatrogenic dependence, with an enhanced understanding of 
the key concepts involved in misuse and recovery pathways.   
 
Key Words 
Codeine, pain, addiction, cognitive behavioural therapy, opioid  
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INTRODUCTION 
Global trends in the misuse of prescription and over the counter (OTC) opioids are driven by 
prescribing trends, forms of patient self-medication and public availability (Collins and 
McAllister, 2006; Cooper, 2013a). Misuse definitions vary, but are broadly defined as ‘the 
use of a medicine, with or without a doctor’s prescription, clearly outside of accepted 
medical practice or guidelines, for recreational purposes or in the framework of self-
medication, in greater dosages or for longer periods than were prescribed, in which the risks 
and problems associated with use outweigh the benefits’ (Casati, Sedefov and Pfeiffer-
Gerschel, 2012:229-230). Public misuse and potential for misuse of codeine containing 
medicines in particular has received attention in recent times in Australia, the United 
Kingdom, Ireland, France and South Africa (McAvoy, Dobbin and Tobin, 2011; Nielsen et 
al., 2015c; Stannard, 2013; Tobin, Dobbin and McAvoy, 2013). Codeine, or 3-
methylmorphine, is a short acting, weak to mid-range opiate (Tremlett, Anderson and Wolf, 
2010). Codeine containing medicines are available (at the time of writing) in OTC 
formulations for the symptomatic relief of mild to moderate pain or cough (Derry, Karlin and 
Moore, 2013), and at varying strengths per country regulatory regime (Van Hout and 
Norman, 2015c). 
Typical side effects of codeine include euphoria, altered perceptions and emotional 
responses to pain, and sedation, and development of tolerance within relatively short time-
frames on repeated use (Babalonis, Lofwall, Nuzzo, Siegel and Walsh, 2013; Frei, Nielsen, 
Dobbin, and Tobin, 2010; Nielsen, Cameron and Pahoki, 2010; Romach, Sproule, Sellers, 
Somer and Busto, 1999; Sproule, Busto, Somer, Romach and Sellers, 1999;). Harms relating 
to excessive and/or long term use of codeine containing medicines are well documented 
(Robinson, G. M., Robinson, S., McCarthy and Cameron, 2010), and often occurring in 
individuals with no history of substance use disorders or co-morbidity (Van Hout et al., 
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2014). Clinical profiles vary and are distinct from other opiate dependents, but include all 
ages, genders, alcohol and poly substance users, patients with chronic pain and/or underlying 
psychiatric conditions (Agyapong et al., 2013; ; Myers, Siegfried and Parry, 2003; Nielsen et 
al., 2008; Nielsen, Cameron and Lee, 2011; Nielsen et al., 2015 a:b; Otto et al., 2009; 
Robinson et al., 2010;   Roussin, Bouyssi, Pouche, Pourcel, & Lapeyre-Mestre, 2013; 
Thekiso and Farren, 2010). Problematic codeine users do not easily recognise problematic 
use or dependence, and view themselves as different to other substance abusers (Cooper, 
2013b; Marr and Hill, 2015;   Nielsen et al., 2010;  Nielsen et al., 2015a; Pates, McBride, Li 
and Ramadan, 2002; Romach et al., 1999).  
Building on this ‘uniqueness’, we used concept mapping (Liese and Esterline, 2015) 
to apply Liese and Franz’s (1996) cognitive developmental model of substance abuse to the 
accounts of two groups of individuals from Ireland (Van Hout, Horan, Santlal, Rich and 
Bergin, 2015b) and South Africa (Van Hout, Rich, Dada Bergin, 2015d) that experienced 
codeine use, misuse and dependence. Concept mapping according to Liese and Esterline 
(2015) advocate case mapping which when shared with the patient, can function as an 
intervention to support behaviour change by presenting methodical generated graphic 
representations of the client’s dynamic relations and pathways toward substance dependence. 
Ultimately this mapping exercise could be used to better integrate specific cognitive and 
behaviour change strategies for those experiencing codeine misuse and dependence, and for 
therapists to better understand the unique challenges of this OTC opiate drug as it relates to 
the role of feelings and emotions as influences for use, environmental influences on 
behaviour change, and limits of self-control (Borland, 2014). We chose the model designed 
by Liese and Franz (1996) as it is compatible within current opiate substitution treatment 
(OST) and harm reduction approaches to treatment (Liese, 2014).  
 
Page 4 of 54PDF For Review
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Experiences of Codeine Use, Misuse and Dependence: Application of Liese and Franz’s Cognitive 
Developmental Model of Substance Abuse   
5 
 
METHODS 
Aim 
To apply Liese and Franz’s (1996) cognitive developmental model of substance abuse to the 
in-depth narrative accounts of two samples of individuals from Ireland and South Africa 
experiencing codeine misuse and dependence. Ethical approval in South Africa was granted 
by the Ethics Committee of the South African Medical Research Council and by Waterford 
Institute of Technology and the National Drug Treatment Centre Board (NDTCB) in Ireland. 
Both studies were conducted in two very distinct regulatory regimes and aimed to garner 
unique individual and collective lived experiences of codeine misuse and dependence, from 
purposive samples of adult codeine misusers and individuals dependent on codeine (actively 
misusing and in recovery) in Ireland (n=21) and South Africa (n=25). Sampling for both the 
Irish and South African studies continued until saturation of the data occurred. We utilised 
extant narratives from these national studies and applied Liese and Franz’s (1996) cognitive 
developmental model of substance abuse  to  concept map a  cognitive behavioural analysis 
of the experiences of codeine misusers – which ‘surfaces’ their specific beliefs, thoughts, 
emotions and behaviours. 
 
Selection of Participants 
Recruitment of participants was facilitated by the National Head Office of the South African 
Council on Alcoholism and Drug Dependence (SANCA) and the NDTCB in Ireland which 
oversee national addiction treatment systems in respective countries. Both national treatment 
organisations nominated key gatekeepers in each treatment centre to provide their patients 
with information on the research study, and ask if they wished to partake in an interview. 
Informants were eligible for interview if they were: citizens of the country in which the 
research was conducted (Ireland or South Africa), 18 years of age or more, reported using 
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codeine in excess of accepted medical guidelines, and scored 5 or more on the Severity of 
Dependence Scale (SDS) (Gossop et al., 1995), a measure of the psychological components 
of codeine dependence; a score of 5 or more on the SDS has been found to identify 
problematic codeine use with a high degree of accuracy (Nielsen et al., 2010).  The 
demographic profile of the participants is reported in Table 1. 
 
Insert Table 1 about here  
 
Interviews 
Interviews lasted between 30 and 90 minutes, and were conducted in treatment and private 
settings. The interview guide was developed based on the literature contained in an extensive 
scoping review on codeine conducted by the team (Van Hout et al., 2014). Questions centred 
on participant choices and decision making to use codeine (prescribed or over the counter), 
experience of sporadic and continued codeine use and misuse, reinforcers for use, misuse and 
dependence, sourcing, awareness of risk and abuse potential, adverse consequences and 
accessing of treatment services.  
 
Analysis 
Narratives were combined and analysed using the Empirical Phenomenological 
Psychological (EPP) five-step method (Karlsson, 1995). This method was used to interpret 
the meaning structure of lived psychological phenomena relating to the subjective codeine 
misuse and dependence experience. A dialectic understanding of the whole picture and it’s 
part-components was used to create an incremental understanding of the relationship between 
the individual and the codeine containing medicine. Above the thematic level, higher levels 
of abstraction were grounded in user lack of awareness of habit forming use, self-
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legitimisation of use and the pre-empting of physical pain, management of emotional distress, 
and the invisible and isolating nature of dependence.  
 
PSYCHOLOGICAL MODEL OF CODEINE MISUSE AND DEPENDENCE  
Shaffer, LaPlante, and Nelson (2012) and Shaffer et al., (2004) view addiction as a syndrome 
with common causes, multiple opportunistic expressions, and with shared neurobiological 
and psychosocial antecedents, and experiences. This syndrome is cognisant of the role of 
individual characteristics, drug used, and environmental factors influencing transitions from 
use to misuse, and ultimately development of dependence. West (2005:2013) whilst 
recognising the heterogeneous nature of mechanisms underlying addiction, underscores the 
effect of motivational dysfunction through the unstable presence of responses, reflexes, 
impulses/inhibitory forces, desires, evaluations (beliefs), and overarching plans which 
interact with the individuals internal and external environment. Addictive behaviours (such as 
misuse of codeine) are viewed by Beck, Wright, Newman and Liese, (1993) as emerging 
from interplay between layers and levels of substance related (anticipatory, relief-oriented, 
and permissive) and facilitative beliefs, and high risk situations which activate automatic 
thoughts, and feelings of urges and cravings to use, within a cycle of addiction.   
A complex interaction between cognitions (beliefs, thoughts, schemas), opinions, 
expectations, values, suppositions, behaviours, emotions, social relationships, cultural 
influences and physiological processes occurs (Alford and Nocross, 1991; Beck and Alford, 
2000).  Beck’s cognitive model of addiction underpins cognitive therapy for substance use, 
through behavioural strategies centring on avoiding high risk situations, finding new coping 
mechanisms, and working with substance related beliefs. In Beck’s model, the expectancies 
of substances are a key difference between those using problematically and those not, and 
with dysfunctional beliefs playing a role in the generation of urges (Beck, Wright, Newman 
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and Liese, 1993; Liese and Franz, 1996), with beliefs and expectancies interacting with the 
emotional, environmental and physiological systems, and facilitating the development and 
maintenance of the disorder (Liese, Beck and Seaton, 1999).   
The model, presented in Figure 1, applies Liese and Franz’s (1996) cognitive 
developmental model of substance abuse, to concept map the cognitive behavioural analysis 
of the distinct and unique experiences of codeine misusers – which ‘surfaces’ their specific 
beliefs, thoughts, emotions and behaviours around misuse and dependence on the legitimately 
used OTC opiate drug, codeine. Liese and Franz’s (1996) model includes a developmental 
component preceding the point of continued use activated by ‘Activating Stimuli’ (See Figure 
1). These earlier factors include early life experiences, development of schemas, basic and 
conditional beliefs, exposure to and experimentation with substances and the development of 
drug related beliefs. This developmental process can influence potential vulnerability for 
codeine use, misuse and dependence. Seven stages are then depicted in the model of acute 
periods of codeine use, misuse and dependence with individuals not necessarily following a 
linear trajectory through the stages identified. The stages are (1) activating stimuli for codeine 
use; (2) beliefs activated; (3) automatic thoughts; (4) transitioning to codeine misuse and 
dependence (urges and cravings) (5) enabling beliefs; (6) instrumental strategies, and (7) 
continued codeine misuse and dependence. See Figure 1.  
 
Insert Figure 1 about here  
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Developmental Stages of Use and Misuse 
The developmental component before point of ‘continued use’ (see Figure 1) explores early 
life experiences, development of schemas, basic beliefs, exposure to and experimentation 
with substances and the development of drug related beliefs. Early life experiences reported 
by participants centred on the ‘loss of a parent’ as a child and the emotional isolation 
experienced ( South African Male , 45 yrs); ‘parental disharmony’ (South African Female, 
43yrs; Irish Male, 31 yrs) and its negative impact on children; history of parents with 
substance misuse and dependence (South African Male, 47 yrs; Irish Male, 31 yrs; Irish 
Female, 42 yrs); parental physical and emotional abuse of children (South African Male, 36 
yrs; South African Male, 47 yrs; Irish Male, 31 yrs); history of childhood behavioural 
problems and the use of medications to manage such challenging behaviours (South African 
Male, 42 yrs); ‘religion’ and associated beliefs formed and held that alcohol was forbidden 
but it was acceptable to use drugs that were legitimately available to purchase over the 
counter (South African Male, 45yrs); to the ‘culture of sports’ and the social acceptance for 
some sports, for example, ‘rugby’ and its association with ‘alcohol use and misuse’ (South 
African Male, 37 yrs).  
Such early life experiences led some participants to develop beliefs that negatively 
impacted upon them. For example, feeling ‘emotionally isolated’ resulted from parental loss; 
‘low self-esteem’ and feelings of worthlessness as a consequence of physical and emotional 
abuse from parents who misused or were dependent on substances. Exposure to and 
experimentation with substances occurred with many individuals reporting exposure ranging 
from parental or sibling addictions to alcohol, nicotine and other substances to participants 
themselves experimenting in the past as teenagers and young adults with ‘ecstasy, … speed, 
(Irish Female, 26 yrs) cannabis’ (Irish Female, 26 yrs; Irish Male, 38 yrs; Irish Female, 42 
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yrs) and ‘cocaine’ (Irish Male, 50 yrs) to their own legitimate use of over the counter and 
prescribed medications for physical conditions related to pain symptomology.  
Specific positive drug related beliefs were developed and maintained in relation to initial 
codeine use. For example, some participants described how initial use of codeine containing 
medicines would make them feel more socially ‘relaxed’ (South African Male, 37 yrs; South 
African Male, 41 yrs; South African Male, 47yrs; South African Male, 74 yrs) similar to the 
effects of alcohol, and also, would enhance their self-confidence. One 31 year old male Irish 
participant describes how:  
‘I was never confident enough… to just go out and talk to people…. And then when I 
was out, I used to take codeine and… I would be very chatty. It’s almost like you’re 
drunk…’ 
A 42 year old male Irish participant highlights how over time he increased his use of codeine 
to sustain feelings of confidence as were previously experienced: 
‘… three…just twenty four [codeine tablets] until they were gone but then I was 
getting to [the] sixties and I wasn’t getting the effect anymore, well I was getting 
it a bit but I wasn’t… as confident as I would be, …[then]… stretching up to 
eighty four [codeine tablets]…’  
In sum, early life experiences, social norms and schemas about the cultural acceptability of 
drugs, combined with exposure to and experimentation with addictive behaviours appears to 
lead to positive beliefs about codeine which reinforces continued use. 
 
Activating Factors 
We distinguish between internal and external precipitating factors that predispose the person 
to risk for using codeine containing medicines. Internal precipitating factors occur within the 
individual, while external factors are contextualised beyond the individual’s psychobiography 
and are situated either within relational or social contexts or both. Examples of internal 
factors are bio-psycho-social in origin and include individuals experiencing physical pain, 
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emotional distress, depression, anxiety, stress related conditions, low self-esteem and a sense 
of an ‘internalised loss’ of control resulting from adverse life events and the use of codeine 
for reducing the perceived impact of psychological trauma.  
External precipitating factors could include adverse life events such as lone parenting, 
unemployment, marital and relationship disharmony and divorce. These experiences of 
‘internalised loss’ lead to relational conflict within social networks often resulting in social 
isolation and loss of support networks. Such internal and external precipitating factors are 
situated within a wider context of the ‘legitimacy’ status of codeine products, ‘advertising of 
products’, ‘pharmacy availability’ and ‘over the counter’ access to codeine containing 
medicines. 
 
Beliefs activated 
Many codeine dependent individuals do not realise they are dependent. Anticipatory and 
relief oriented beliefs are formed as a consequence of internal and external activating factors. 
Anticipatory beliefs that are convincingly held, centre around the efficacy and pleasures 
associated with use and misuse whereby codeine is viewed as ‘my helper’ and ‘companion’. 
The presence of emotional pain and self-legitimisation of use is a common belief. 
‘Pain killers are not just for what is written on the back of the pack, they should 
add also pain relief from anxiety, depression and heartache.’ (Irish Female, 
26yrs) 
Automatic beliefs that codeine containing medicines can ‘manage discrete episodes of 
physical pain’, ‘deny or suppress psychological symptoms’ and ‘lift up moods’ are held. Such 
beliefs range from relief oriented beliefs, and involve the expectation of reprieve from 
physical and emotional symptoms, for example, helping them to relax, to beliefs relating to 
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mood elevation and regulation. Such automatic or involuntary thoughts sustain the 
convincingly held beliefs that ‘codeine is my helper’ and ‘codeine is my companion’. 
‘I wasn’t expecting the high I got but I was very happy with its effects, it felt like 
the missing piece to my life.’ (Irish Female, 26yrs) 
Automatic thoughts 
Involuntary or automatic thoughts are described as a consequence to deeply held beliefs, such 
as ‘codeine is my helper’ and ‘codeine is my companion’. Such beliefs contribute to the 
development of the role of codeine as ‘crutch’; ‘friend’ and ‘helper’ in correspondence with 
dependence and to the detriment of ‘real life social relations’. Automatic thoughts triggered 
that are brief and spontaneous in relation to such basic beliefs include ‘feel better’; ‘improved 
life’; ‘get them’; ‘a rush’. As two Irish participants stated: 
‘I always deep down knew I was abusing it but some of my thoughts were, so what? 
It’s serving you a purpose, it’s making life better, it’s only an over the counter drug. I 
used it for just under a year’ (Irish Male, 30yrs). 
 
‘I used to take it [codeine tablets] then just to make myself feel better. When I used to 
get up and feel crap, I’ll take it and feel instantly better. That is what I used to do. 
That is what I still do; and now it’s like it has become part of my daily routine in my 
daily life. … I’d get very uplifted when I was using that stuff [codeine tablets]’ (Irish 
Male, 31 yrs). 
Images as automatic thoughts were sometimes described, for example, ‘fizzy effect’ following 
use of soluble codeine medications and its pleasurable effects. One male participant described 
how ‘soluble codeines in water with that fizzy effect… it gave me the hit and it gave me a 
rush’ (Irish Male, 38 yrs). This association between drugs related beliefs and thoughts lead 
the individual to desire codeine containing medicines and ‘…to consume in order to function 
throughout the day’. This creates a context whereby certain convincingly held beliefs are 
maintained.  
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Transitioning to misuse and dependence  
Many individuals described their use of codeine containing medicines as appropriate and 
consumed for legitimate reasons, prescribed or OTC and were largely unaware of codeine’s 
abuse and dependence potential and the possible harms. Some are totally unaware of their 
physical dependence to codeine despite an increase in their use; desire to continue to misuse 
and not being able to stop.  
‘It creeps up on you particularly if you’ve got an addictive personality.’ (South 
African Male, 38yrs). 
Awareness of habit forming use and related tolerance is a gradual and subtle process with 
often a sudden realisation that they were consuming more than normal, sometimes 
recreationally, with their ‘bodies’ experiencing withdrawal and requiring more codeine 
containing medicines. This pattern of use would ‘escalate’ especially as a result of on-going 
life events negatively impacting upon their lives reinforced by beliefs that ‘codeine is my 
helper’ and ‘codeine is my companion’. We failed to pinpoint any cultural or gender related 
differences in the codeine use, misuse and dependence pathway, and speculate that this is due 
to the similarities in over the counter availability, legitimisation via prescriber and pharmacist 
routes of supply, and tolerance of alcohol and other drugs by wider societal forces.  
 
Enabling beliefs 
Enabling beliefs are held which facilitate self-permissiveness or reinforce a sense of 
entitlement to continue misusing codeine containing medicines. Two specific enabling beliefs 
were identified. The first centred on the misuse of codeine as a coping mechanism to manage 
and pre-empt the occurrence of physical and psychological distress, in many cases relating to 
severe trauma and distress.  
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‘Eventually there was not any pain, but I was scared of the pain in my mind’ 
(South African Male, 47yrs). 
‘Very quickly it was not enough in the morning to have me floating, feeling 
euphoric, and care free really. I was numb and I liked that. Codeine filled a void.’ 
(Irish Female, 32yrs). 
 The second enabling belief highlights the importance of adverse social circumstances in 
underpinning codeine dependence pathways, so justifying codeine misuse as a novel adaptive 
coping mechanism for managing life stressors.  
‘I actually abused the codeine to supress my depression and to give that euphoric 
effect. I felt a lot of isolation, guilt and grief.’ (South African Male, 36yrs).  
 
Instrumental strategies 
Once individuals grant themselves permission to use codeine containing medicines, their 
focus moves to instrumental (behavioural and cognitive) strategies to secure the medicines 
either through legitimate sources (multiple pharmacy purchasing, ‘doctor hopping’) or via the 
‘black market’ . Participants explained:  
‘….it became a very engrained thing for me [to do].’ (Male South African, 21yrs). 
‘An addiction will find a way, there’s always a way. When you want something 
you will always find a way to get it.’ (Irish Female, 45 yrs) 
Legitimate sourcing involves behaviours that are deceptive and manipulative involving lying, 
faking illness or exaggerating symptoms to secure a script or supply of the medicine.  
 ‘Exaggerating symptoms and manipulating the conversation. I always had an 
answer. ’ (South African Male, 38yrs). 
Habitual daily therapeutic and non-therapeutic use escalates with high dosages consumed 
within a short time frame. This often occurs as a result of failure to develop alternative 
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coping strategies in relation to physical and emotional pain. Individuals recognise their 
problem with regard to their daily use and misuse which leads in turn to ‘self-legitimisation’ 
based upon their need to use codeine inappropriately. This need to use inappropriately is 
reinforced by a somatic ‘recognition of liking the opiate effect’, ‘pleasurable effects’ and 
‘codeine giving a buzz’  with increased tolerance to adverse effects such as withdrawals, 
medication overuse headache, nausea, constipation, tachycardia and palpitations. 
 
Continued misuse and dependence  
Adopting instrumental (behavioural and cognitive) strategies, individuals are likely to 
continue to source and use and misuse codeine leading to dependence.  
‘Addiction teaches you master manipulation. No matter what barriers you build 
an addict’s mind goes far beyond it.’ (Irish Female, 26yrs). 
 Beliefs held with conviction that ‘codeine is my helper’, ‘codeine is my companion’ and 
‘self-legitimisation’ reinforce their continued misuse and dependence. This process is further 
reinforced by pre-existing internal and external precipitating factors that predispose them to 
risk of using, misusing and dependence, and a ‘fear of stopping’.  
‘My friends are gone and it’s more a companion addiction.  It feels like it has its 
arm around you. It gives me that sense of security and that’s what I’m struggling 
with at the moment, it’s to break that cycle.’ (Irish Male, 31yrs). 
 
DISCUSSION  
Liese and Franz’s (1996) cognitive developmental model of substance abuse is applied to the 
in-depth narrative accounts of a sample of individuals experiencing codeine misuse and 
dependence. A cognitive behavioural mapping of the psychological processes involved in 
transitioning from codeine use, to misuse and toward dependence is presented. Illustrations  
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of the unique nature of these individuals’ experiences and pathways by virtue of codeine as a 
legitimately sourced OTC opiate drug despite carrying risk of habitual and dependent use, the 
accidental nature of inadvertent dependence, and interplay with various forms of physical and 
emotional pain, which ultimately creates difficulties in successful recovery. Reinforcers, 
triggers, and thoughts are influenced by the thought processes around use, the pharmacy retail 
environment, and to a lesser extent prescribing patterns.  Ultimately we sought to create 
greater understanding of codeine misuse and dependence in order to better inform the design 
of appropriate psychological treatment plans within existing OST management systems. The 
need to better understand and intervene with those requiring support for problematic codeine 
use is well evidenced in contemporary literature (Marr and Hill, 2015; Nielsen et al., 2015a; 
Nielsen et al., 2010; Pates et al., 2002).  
Reliability and validity of the qualitative research process and the application of 
findings to Liese and Franz’s (1996) cognitive developmental model of substance abuse  are 
enhanced by the trustworthiness of the data used (Lincoln and Guba, 1985), which contain 
extensive and consistent similarities in the misuse and dependence phenomenon across the 
lived experiences and social circumstances in both countries, one in the developed, and the 
other in the developing world (Van Hout, et al., 2015b; Van Hout et al., 2015d). Horizontal 
and vertical consistencies are visible in the interpretation of the codeine misuse and 
dependence phenomena, despite variance in cultural contexts, social circumstances and 
regulatory availability in each country. In terms of ‘generalisability’ both qualitative studies 
were underpinned by a constructivist approach that guided sampling, data collection and 
analysis and we do not claim that ‘generalisability’ was achieved. However, reliability of the 
data sources and validity of the model is further supported by triangulation of these 
qualitative studies, and the generated model itself against accounts of pathways to codeine 
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misuse reported by other studies conducted in the United Kingdom (Cooper, 2011, 2013b), 
and Australia (Nielsen et al., 2010; Nielsen et al., 2011; Nielsen, Cameron and Pahoki, 2013).  
Borland (2014) advocates the need to consider how a ‘hard to maintain’ behaviour is 
maintained, whether by the skills required to perform it, reinforcement patterns, cognitive 
thought processes, environmental factors, or a multiplicity of these factors, and that such 
behaviour is often not available for conscious awareness.  Codeine misuse and dependence 
pathways appear to be maintained by the interplay between physiological determinants 
relating to pain, withdrawal and tolerance, and psychological influences. These influences 
include therapeutic need and use pre-empting of anticipated physical pain, recognition of 
appreciation of the opiate sedative therapeutic effect both for legitimate therapeutic and non-
therapeutic reasons. Iatrogenic dependence contributes to the blurring between therapeutic 
use and problematic use of codeine containing medicines. Progression toward habitual use, 
dose escalation and medication of withdrawal and anxiety related symptoms appears 
mediated by external environmental triggers pertaining to availability, and internal meta-
cognitions around physical pain and emotional distress, and the significance of the role 
codeine assumes for the user.  
Given codeine users’ unique experiences with a legitimately available opiate drug, 
lack of self-identification of habit forming use and pathways toward dependence, those 
patients do require psychological treatment interventions particular to their needs and in order 
for recovery to occur (Kean, 2015; Nielsen et al., 2011; Nielsen et al., 2015c; Van Hout, 
Delargy, Ryan, Flanagan and Gallagher, 2015a).  The recognition of iatrogenic dependence in 
these patients warrants particular psycho-social interventions alongside the management of 
pain (Hard, 2014; Marr and Hill, 2015).  Targeted psycho-social cognitive based 
interventions are warranted for this distinct group of opiate dependents (Kean, 2015; Van 
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Hout et al., 2015a;  Van Hout et al., 2015b; Van Hout et al., 2015d) and particularly those 
which target client conscious awareness of transitioning of misuse toward dependence 
(Borland, 2014; West, 2005: 2013). The model is intended to help therapists integrate 
cognitive and behaviour change strategies (for example mindfulness and acceptance), with an 
understanding of the distinct challenges for these patients in navigating pharmacies when in 
recovery, the role of trauma and distress in increasing their vulnerability, and coping 
mechanisms needed for successful rehabilitation. The role of codeine containing medicines 
appears grounded in self-regulation vulnerabilities (Khantzian, 1997; Nielsen et al., 2010). 
Cognitive conceptualisation can thus be reformulated during therapy, whilst gathering 
additional client information, experiences and evidence. Physiological, behavioural and social 
triggers, along with the interplay of anticipatory, relief-oriented, and permissive beliefs can 
contribute to relapse, even in the absence of physiological symptoms such as pain.   
 
CONCLUSION  
Psychological interventions for codeine dependence should take account of the reinforcing 
cycles of physical pain, emotional distress and codeine misuse. This model could provide 
psychological therapists working with individuals experiencing problems with codeine, 
misusing codeine and those with iatrogenic dependence with an enhanced understanding of 
the key concepts involved in these unique dependence and recovery pathways. 
 
The authors assert that all procedures contributing to this work comply with the ethical 
standards of Waterford Institute of Technology, Ireland and the South African Medical 
Research Council and with the Helsinki Declaration of 1975, and its most recent revision. 
 
The authors have no conflict of interest with respect to this publication. 
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Figure 1 Cognitive Developmental Model depicting use, misuse and dependence of codeine 
containing medicines (Adapted from: Liese & Franz, 1996) 
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potential and harms 
Enabling Beliefs: 
Self-permission and entitlement 
to use based on 'legitimate 
availability' 
Automatic Thoughts: 
‘Feel better’  
‘Improved life’  
‘Get them’ 
‘Take one’ 
‘A rush’ 
‘Fizzy effect’ 
Instrumental Strategies 
behavioural and cognitive 
approaches  
'pharmacy and alternative 
sourcing' 
'self-legitimisation’ 
Continued Misuse and Dependence:  
'fear of stopping' 
'loss of social support' 
'use of other drugs' 
Beliefs Activated:  
Beliefs held with a high degree of 
conviction include 
'Codeine is my helper' 
'Codeine is my companion’ 
 
 
Activating Factors for Use: 
internal and external 
precipitating factors that are 
bio-psycho-social  in origin. 
'legitimacy of codeine 
medicines’ 
Early life experiences: 
Parental disharmony; loss of a parent during childhood; 
parents with history of substance misuse and dependence; 
abuse; culture and social acceptance of substance misuse 
Exposure to and experimentation with 
addictive behaviours: 
Exposure by parents and siblings to substance 
misuse and dependence; 
Self-experimentation with alcohol and other 
drugs (legitimate and illegitimate use) 
 
Schemas and basic beliefs: 
‘Cultural acceptance of use of alcohol’  
Religious beliefs against use of alcohol but acceptance of 
use of prescribed drugs; 
‘Legitimate permission for use of over-the-counter drugs’ 
 
Development of drug related beliefs:  
Taking codeine:  
‘makes me feel confident’; 
Similar to taking alcohol and feeling 
‘like your drunk’ 
 
Continued Use: 
Beliefs noticeable, prevalent and 
accessible reinforcing continued 
use and vulnerability to misuse 
and potential dependence. 
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Table 1 Participant Profile 
 
Ireland  South Africa 
Gender 
57% female  
43% male. 
Gender 
40% female  
60% male 
Age Range 
26 to 62 years   
Mean age of 39 years 
Standard Deviation 12.42 
Age Range 
21 to 74 years  
Mean age of 43 years  
Standard Deviation 9.93 
Employment Status 
52% unemployed 
Employment Status 
64% unemployed  
Use of Codeine  
72% used codeine within the last 12 months.   
90% reported codeine analgesics as primary 
problematic drug. 
 
Use of Codeine 
80% used codeine within the last 12 months. 
32% reported codeine analgesics as primary 
problematic drug. 
20% reported codeine antitussive syrup as 
primary problematic drug. 
SDS Score 
80% scored 10 or above  
SDS Score 
52% scored 10 or above  
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ABSTRACT 
Background 
Misuse of codeine containing medicines is an emerging public health issue.  
Aims 
We present the application of Liese and Franz’s (1996) cognitive developmental model of 
substance abuse to the trajectory from legitimate codeine use for pain, toward that of 
therapeutic and other forms of misuse, and physical and psychological dependence. It 
illustrates a cognitive behavioural analysis of the experiences of codeine misusers – which 
‘surfaces’ the specific beliefs, thoughts, emotions and behaviours of this group of hidden 
codeine dependent individuals, who are distinct and unique from other opioid dependent 
cohorts.  
Methods:  
In-depth one-to-one interviews with codeine misusers and dependent individuals in Ireland 
(n=21), and South Africa (n=25) are analysed and applied to Liese and Franz’s (1996) 
cognitive developmental model of substance abuse.  
Results 
Misuse and dependence pathways are maintained by the interplay between physiological 
determinants relating to pain, withdrawal and tolerance, and psychological influences such as 
therapeutic need, pre-empting of anticipated physical pain, pleasure from the dreamy sedative 
opiate effect of codeine and relief of emotional distress. Progression toward habitual use and 
misuse for therapeutic and intoxication purposes appears mediated by external environmental 
triggers pertaining to availability, internal meta-cognitions around physical pain and 
emotional distress, and increasing  importance of codeine in the life of the user.  
Conclusion 
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The concept mapping of codeine misuse and dependence presented here could provide 
psychological therapists working with individuals experiencing problems with codeine, 
misusing codeine and those with iatrogenic dependence, with an enhanced understanding of 
the key concepts involved in misuse and recovery pathways.   
 
Key Words 
Codeine, pain, addiction, cognitive behavioural therapy, opioid  
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INTRODUCTION 
Global trends in the misuse of prescription and over the counter (OTC) opioids are driven by 
prescribing trends, forms of patient self-medication and public availability (Collins and 
McAllister, 2006; Cooper, 2013a). Misuse definitions vary, but are broadly defined as ‘the 
use of a medicine, with or without a doctor’s prescription, clearly outside of accepted 
medical practice or guidelines, for recreational purposes or in the framework of self-
medication, in greater dosages or for longer periods than were prescribed, in which the risks 
and problems associated with use outweigh the benefits’ (Casati, Sedefov and Pfeiffer-
Gerschel, 2012:229-230). Public misuse and potential for misuse of codeine containing 
medicines in particular has received attention in recent times in Australia, the United 
Kingdom, Ireland, France and South Africa (McAvoy, Dobbin and Tobin, 2011; Nielsen et 
al., 2015c; Stannard, 2013; Tobin, Dobbin and McAvoy, 2013). Codeine, or 3-
methylmorphine, is a short acting, weak to mid-range opiate (Tremlett, Anderson and Wolf, 
2010). Codeine containing medicines are available (at the time of writing) in OTC 
formulations for the symptomatic relief of mild to moderate pain or cough (Derry, Karlin and 
Moore, 2013), and at varying strengths per country regulatory regime (Van Hout and 
Norman, 2015c). 
Typical side effects of codeine include euphoria, altered perceptions and emotional 
responses to pain, and sedation, and development of tolerance within relatively short time-
frames on repeated use (Babalonis, Lofwall, Nuzzo, Siegel and Walsh, 2013; Frei, Nielsen, 
Dobbin, and Tobin, 2010; Nielsen, Cameron and Pahoki, 2010; Romach, Sproule, Sellers, 
Somer and Busto, 1999; Sproule, Busto, Somer, Romach and Sellers, 1999;). Harms relating 
to excessive and/or long term use of codeine containing medicines are well documented 
(Robinson, G. M., Robinson, S., McCarthy and Cameron, 2010), and often occurring in 
individuals with no history of substance use disorders or co-morbidity (Van Hout et al., 
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2014). Clinical profiles vary and are distinct from other opiate dependents, but include all 
ages, genders, alcohol and poly substance users, patients with chronic pain and/or underlying 
psychiatric conditions (Agyapong et al., 2013; ; Myers, Siegfried and Parry, 2003; Nielsen et 
al., 2008; Nielsen, Cameron and Lee, 2011; Nielsen et al., 2015 a:b; Otto et al., 2009; 
Robinson et al., 2010;   Roussin, Bouyssi, Pouche, Pourcel, & Lapeyre-Mestre, 2013; 
Thekiso and Farren, 2010). Problematic codeine users do not easily recognise problematic 
use or dependence, and view themselves as different to other substance abusers (Cooper, 
2013b; Marr and Hill, 2015;   Nielsen et al., 2010;  Nielsen et al., 2015a; Pates, McBride, Li 
and Ramadan, 2002; Romach et al., 1999).  
Building on this ‘uniqueness’, we used concept mapping (Liese and Esterline, 2015) 
to apply Liese and Franz’s (1996) cognitive developmental model of substance abuse to the 
accounts of two groups of individuals from Ireland (Van Hout, Horan, Santlal, Rich and 
Bergin, 2015b) and South Africa (Van Hout, Rich, Dada Bergin, 2015d) that experienced 
codeine use, misuse and dependence. Concept mapping according to Liese and Esterline 
(2015) advocate case mapping which when shared with the patient, can function as an 
intervention to support behaviour change by presenting methodical generated graphic 
representations of the client’s dynamic relations and pathways toward substance dependence. 
Ultimately this mapping exercise could be used to better integrate specific cognitive and 
behaviour change strategies for those experiencing codeine misuse and dependence, and for 
therapists to better understand the unique challenges of this OTC opiate drug as it relates to 
the role of feelings and emotions as influences for use, environmental influences on 
behaviour change, and limits of self-control (Borland, 2014). We chose the model designed 
by Liese and Franz (1996) as it is compatible within current opiate substitution treatment 
(OST) and harm reduction approaches to treatment (Liese, 2014).  
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METHODS 
Aim 
To apply Liese and Franz’s (1996) cognitive developmental model of substance abuse to the 
in-depth narrative accounts of two samples of individuals from Ireland and South Africa 
experiencing codeine misuse and dependence. Ethical approval in South Africa was granted 
by the Ethics Committee of the South African Medical Research Council and by Waterford 
Institute of Technology and the National Drug Treatment Centre Board (NDTCB) in Ireland. 
Both studies were conducted in two very distinct regulatory regimes and aimed to garner 
unique individual and collective lived experiences of codeine misuse and dependence, from 
purposive samples of adult codeine misusers and individuals dependent on codeine (actively 
misusing and in recovery) in Ireland (n=21) and South Africa (n=25). Sampling for both the 
Irish and South African studies continued until saturation of the data occurred. We utilised 
extant narratives from these national studies and applied Liese and Franz’s (1996) cognitive 
developmental model of substance abuse  to  concept map a  cognitive behavioural analysis 
of the experiences of codeine misusers – which ‘surfaces’ their specific beliefs, thoughts, 
emotions and behaviours. 
 
Selection of Participants 
Recruitment of participants was facilitated by the National Head Office of the South African 
Council on Alcoholism and Drug Dependence (SANCA) and the NDTCB in Ireland which 
oversee national addiction treatment systems in respective countries. Both national treatment 
organisations nominated key gatekeepers in each treatment centre to provide their patients 
with information on the research study, and ask if they wished to partake in an interview. 
Informants were eligible for interview if they were: citizens of the country in which the 
research was conducted (Ireland or South Africa), 18 years of age or more, reported using 
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codeine in excess of accepted medical guidelines, and scored 5 or more on the Severity of 
Dependence Scale (SDS) (Gossop et al., 1995), a measure of the psychological components 
of codeine dependence; a score of 5 or more on the SDS has been found to identify 
problematic codeine use with a high degree of accuracy (Nielsen et al., 2010).  The 
demographic profile of the participants is reported in Table 1. 
 
Insert Table 1 about here  
 
Interviews 
Interviews lasted between 30 and 90 minutes, and were conducted in treatment and private 
settings. The interview guide was developed based on the literature contained in an extensive 
scoping review on codeine conducted by the team (Van Hout et al., 2014). Questions centred 
on participant choices and decision making to use codeine (prescribed or over the counter), 
experience of sporadic and continued codeine use and misuse, reinforcers for use, misuse and 
dependence, sourcing, awareness of risk and abuse potential, adverse consequences and 
accessing of treatment services.  
 
Analysis 
Narratives were combined and analysed using the Empirical Phenomenological 
Psychological (EPP) five-step method (Karlsson, 1995). This method was used to interpret 
the meaning structure of lived psychological phenomena relating to the subjective codeine 
misuse and dependence experience. A dialectic understanding of the whole picture and it’s 
part-components was used to create an incremental understanding of the relationship between 
the individual and the codeine containing medicine. Above the thematic level, higher levels 
of abstraction were grounded in user lack of awareness of habit forming use, self-
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legitimisation of use and the pre-empting of physical pain, management of emotional distress, 
and the invisible and isolating nature of dependence.  
 
PSYCHOLOGICAL MODEL OF CODEINE MISUSE AND DEPENDENCE  
Shaffer, LaPlante, and Nelson (2012) and Shaffer et al., (2004) view addiction as a syndrome 
with common causes, multiple opportunistic expressions, and with shared neurobiological 
and psychosocial antecedents, and experiences. This syndrome is cognisant of the role of 
individual characteristics, drug used, and environmental factors influencing transitions from 
use to misuse, and ultimately development of dependence. West (2005:2013) whilst 
recognising the heterogeneous nature of mechanisms underlying addiction, underscores the 
effect of motivational dysfunction through the unstable presence of responses, reflexes, 
impulses/inhibitory forces, desires, evaluations (beliefs), and overarching plans which 
interact with the individuals internal and external environment. Addictive behaviours (such as 
misuse of codeine) are viewed by Beck, Wright, Newman and Liese, (1993) as emerging 
from interplay between layers and levels of substance related (anticipatory, relief-oriented, 
and permissive) and facilitative beliefs, and high risk situations which activate automatic 
thoughts, and feelings of urges and cravings to use, within a cycle of addiction.   
A complex interaction between cognitions (beliefs, thoughts, schemas), opinions, 
expectations, values, suppositions, behaviours, emotions, social relationships, cultural 
influences and physiological processes occurs (Alford and Nocross, 1991; Beck and Alford, 
2000).  Beck’s cognitive model of addiction underpins cognitive therapy for substance use, 
through behavioural strategies centring on avoiding high risk situations, finding new coping 
mechanisms, and working with substance related beliefs. In Beck’s model, the expectancies 
of substances are a key difference between those using problematically and those not, and 
with dysfunctional beliefs playing a role in the generation of urges (Beck, Wright, Newman 
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and Liese, 1993; Liese and Franz, 1996), with beliefs and expectancies interacting with the 
emotional, environmental and physiological systems, and facilitating the development and 
maintenance of the disorder (Liese, Beck and Seaton, 1999).   
The model, presented in Figure 1, applies Liese and Franz’s (1996) cognitive 
developmental model of substance abuse, to concept map the cognitive behavioural analysis 
of the distinct and unique experiences of codeine misusers – which ‘surfaces’ their specific 
beliefs, thoughts, emotions and behaviours around misuse and dependence on the legitimately 
used OTC opiate drug, codeine. Liese and Franz’s (1996) model includes a developmental 
component preceding the point of continued use activated by ‘Activating Stimuli’ (See Figure 
1). These earlier factors include early life experiences, development of schemas, basic and 
conditional beliefs, exposure to and experimentation with substances and the development of 
drug related beliefs. This developmental process can influence potential vulnerability for 
codeine use, misuse and dependence. Seven stages are then depicted in the model of acute 
periods of codeine use, misuse and dependence with individuals not necessarily following a 
linear trajectory through the stages identified. The stages are (1) activating stimuli for codeine 
use; (2) beliefs activated; (3) automatic thoughts; (4) transitioning to codeine misuse and 
dependence (urges and cravings) (5) enabling beliefs; (6) instrumental strategies, and (7) 
continued codeine misuse and dependence. See Figure 1.  
 
Insert Figure 1 about here  
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Developmental Stages of Use and Misuse 
The developmental component before point of ‘continued use’ (see Figure 1) explores early 
life experiences, development of schemas, basic beliefs, exposure to and experimentation 
with substances and the development of drug related beliefs. Early life experiences reported 
by participants centred on the ‘loss of a parent’ as a child and the emotional isolation 
experienced ( South African Male , 45 yrs); ‘parental disharmony’ (South African Female, 
43yrs; Irish Male, 31 yrs) and its negative impact on children; history of parents with 
substance misuse and dependence (South African Male, 47 yrs; Irish Male, 31 yrs; Irish 
Female, 42 yrs); parental physical and emotional abuse of children (South African Male, 36 
yrs; South African Male, 47 yrs; Irish Male, 31 yrs); history of childhood behavioural 
problems and the use of medications to manage such challenging behaviours (South African 
Male, 42 yrs); ‘religion’ and associated beliefs formed and held that alcohol was forbidden 
but it was acceptable to use drugs that were legitimately available to purchase over the 
counter (South African Male, 45yrs); to the ‘culture of sports’ and the social acceptance for 
some sports, for example, ‘rugby’ and its association with ‘alcohol use and misuse’ (South 
African Male, 37 yrs).  
Such early life experiences led some participants to develop beliefs that negatively 
impacted upon them. For example, feeling ‘emotionally isolated’ resulted from parental loss; 
‘low self-esteem’ and feelings of worthlessness as a consequence of physical and emotional 
abuse from parents who misused or were dependent on substances. Exposure to and 
experimentation with substances occurred with many individuals reporting exposure ranging 
from parental or sibling addictions to alcohol, nicotine and other substances to participants 
themselves experimenting in the past as teenagers and young adults with ‘ecstasy, … speed, 
(Irish Female, 26 yrs) cannabis’ (Irish Female, 26 yrs; Irish Male, 38 yrs; Irish Female, 42 
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yrs) and ‘cocaine’ (Irish Male, 50 yrs) to their own legitimate use of over the counter and 
prescribed medications for physical conditions related to pain symptomology.  
Specific positive drug related beliefs were developed and maintained in relation to initial 
codeine use. For example, some participants described how initial use of codeine containing 
medicines would make them feel more socially ‘relaxed’ (South African Male, 37 yrs; South 
African Male, 41 yrs; South African Male, 47yrs; South African Male, 74 yrs) similar to the 
effects of alcohol, and also, would enhance their self-confidence. One 31 year old male Irish 
participant describes how:  
‘I was never confident enough… to just go out and talk to people…. And then when I 
was out, I used to take codeine and… I would be very chatty. It’s almost like you’re 
drunk…’ 
A 42 year old male Irish participant highlights how over time he increased his use of codeine 
to sustain feelings of confidence as were previously experienced: 
‘… three…just twenty four [codeine tablets] until they were gone but then I was 
getting to [the] sixties and I wasn’t getting the effect anymore, well I was getting 
it a bit but I wasn’t… as confident as I would be, …[then]… stretching up to 
eighty four [codeine tablets]…’  
In sum, early life experiences, social norms and schemas about the cultural acceptability of 
drugs, combined with exposure to and experimentation with addictive behaviours appears to 
lead to positive beliefs about codeine which reinforces continued use. 
 
Activating Factors 
We distinguish between internal and external precipitating factors that predispose the person 
to risk for using codeine containing medicines. Internal precipitating factors occur within the 
individual, while external factors are contextualised beyond the individual’s psychobiography 
and are situated either within relational or social contexts or both. Examples of internal 
factors are bio-psycho-social in origin and include individuals experiencing physical pain, 
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emotional distress, depression, anxiety, stress related conditions, low self-esteem and a sense 
of an ‘internalised loss’ of control resulting from adverse life events and the use of codeine 
for reducing the perceived impact of psychological trauma.  
External precipitating factors could include adverse life events such as lone parenting, 
unemployment, marital and relationship disharmony and divorce. These experiences of 
‘internalised loss’ lead to relational conflict within social networks often resulting in social 
isolation and loss of support networks. Such internal and external precipitating factors are 
situated within a wider context of the ‘legitimacy’ status of codeine products, ‘advertising of 
products’, ‘pharmacy availability’ and ‘over the counter’ access to codeine containing 
medicines. 
 
Beliefs activated 
Many codeine dependent individuals do not realise they are dependent. Anticipatory and 
relief oriented beliefs are formed as a consequence of internal and external activating factors. 
Anticipatory beliefs that are convincingly held, centre around the efficacy and pleasures 
associated with use and misuse whereby codeine is viewed as ‘my helper’ and ‘companion’. 
The presence of emotional pain and self-legitimisation of use is a common belief. 
‘Pain killers are not just for what is written on the back of the pack, they should 
add also pain relief from anxiety, depression and heartache.’ (Irish Female, 
26yrs) 
Automatic beliefs that codeine containing medicines can ‘manage discrete episodes of 
physical pain’, ‘deny or suppress psychological symptoms’ and ‘lift up moods’ are held. Such 
beliefs range from relief oriented beliefs, and involve the expectation of reprieve from 
physical and emotional symptoms, for example, helping them to relax, to beliefs relating to 
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mood elevation and regulation. Such automatic or involuntary thoughts sustain the 
convincingly held beliefs that ‘codeine is my helper’ and ‘codeine is my companion’. 
‘I wasn’t expecting the high I got but I was very happy with its effects, it felt like 
the missing piece to my life.’ (Irish Female, 26yrs) 
Automatic thoughts 
Involuntary or automatic thoughts are described as a consequence to deeply held beliefs, such 
as ‘codeine is my helper’ and ‘codeine is my companion’. Such beliefs contribute to the 
development of the role of codeine as ‘crutch’; ‘friend’ and ‘helper’ in correspondence with 
dependence and to the detriment of ‘real life social relations’. Automatic thoughts triggered 
that are brief and spontaneous in relation to such basic beliefs include ‘feel better’; ‘improved 
life’; ‘get them’; ‘a rush’. As two Irish participants stated: 
‘I always deep down knew I was abusing it but some of my thoughts were, so what? 
It’s serving you a purpose, it’s making life better, it’s only an over the counter drug. I 
used it for just under a year’ (Irish Male, 30yrs). 
 
‘I used to take it [codeine tablets] then just to make myself feel better. When I used to 
get up and feel crap, I’ll take it and feel instantly better. That is what I used to do. 
That is what I still do; and now it’s like it has become part of my daily routine in my 
daily life. … I’d get very uplifted when I was using that stuff [codeine tablets]’ (Irish 
Male, 31 yrs). 
Images as automatic thoughts were sometimes described, for example, ‘fizzy effect’ following 
use of soluble codeine medications and its pleasurable effects. One male participant described 
how ‘soluble codeines in water with that fizzy effect… it gave me the hit and it gave me a 
rush’ (Irish Male, 38 yrs). This association between drugs related beliefs and thoughts lead 
the individual to desire codeine containing medicines and ‘…to consume in order to function 
throughout the day’. This creates a context whereby certain convincingly held beliefs are 
maintained.  
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Transitioning to misuse and dependence  
Many individuals described their use of codeine containing medicines as appropriate and 
consumed for legitimate reasons, prescribed or OTC and were largely unaware of codeine’s 
abuse and dependence potential and the possible harms. Some are totally unaware of their 
physical dependence to codeine despite an increase in their use; desire to continue to misuse 
and not being able to stop.  
‘It creeps up on you particularly if you’ve got an addictive personality.’ (South 
African Male, 38yrs). 
Awareness of habit forming use and related tolerance is a gradual and subtle process with 
often a sudden realisation that they were consuming more than normal, sometimes 
recreationally, with their ‘bodies’ experiencing withdrawal and requiring more codeine 
containing medicines. This pattern of use would ‘escalate’ especially as a result of on-going 
life events negatively impacting upon their lives reinforced by beliefs that ‘codeine is my 
helper’ and ‘codeine is my companion’. We failed to pinpoint any cultural or gender related 
differences in the codeine use, misuse and dependence pathway, and speculate that this is due 
to the similarities in over the counter availability, legitimisation via prescriber and pharmacist 
routes of supply, and tolerance of alcohol and other drugs by wider societal forces.  
 
Enabling beliefs 
Enabling beliefs are held which facilitate self-permissiveness or reinforce a sense of 
entitlement to continue misusing codeine containing medicines. Two specific enabling beliefs 
were identified. The first centred on the misuse of codeine as a coping mechanism to manage 
and pre-empt the occurrence of physical and psychological distress, in many cases relating to 
severe trauma and distress.  
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‘Eventually there was not any pain, but I was scared of the pain in my mind’ 
(South African Male, 47yrs). 
‘Very quickly it was not enough in the morning to have me floating, feeling 
euphoric, and care free really. I was numb and I liked that. Codeine filled a void.’ 
(Irish Female, 32yrs). 
 The second enabling belief highlights the importance of adverse social circumstances in 
underpinning codeine dependence pathways, so justifying codeine misuse as a novel adaptive 
coping mechanism for managing life stressors.  
‘I actually abused the codeine to supress my depression and to give that euphoric 
effect. I felt a lot of isolation, guilt and grief.’ (South African Male, 36yrs).  
 
Instrumental strategies 
Once individuals grant themselves permission to use codeine containing medicines, their 
focus moves to instrumental (behavioural and cognitive) strategies to secure the medicines 
either through legitimate sources (multiple pharmacy purchasing, ‘doctor hopping’) or via the 
‘black market’ . Participants explained:  
‘….it became a very engrained thing for me [to do].’ (Male South African, 21yrs). 
‘An addiction will find a way, there’s always a way. When you want something 
you will always find a way to get it.’ (Irish Female, 45 yrs) 
Legitimate sourcing involves behaviours that are deceptive and manipulative involving lying, 
faking illness or exaggerating symptoms to secure a script or supply of the medicine.  
 ‘Exaggerating symptoms and manipulating the conversation. I always had an 
answer. ’ (South African Male, 38yrs). 
Habitual daily therapeutic and non-therapeutic use escalates with high dosages consumed 
within a short time frame. This often occurs as a result of failure to develop alternative 
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coping strategies in relation to physical and emotional pain. Individuals recognise their 
problem with regard to their daily use and misuse which leads in turn to ‘self-legitimisation’ 
based upon their need to use codeine inappropriately. This need to use inappropriately is 
reinforced by a somatic ‘recognition of liking the opiate effect’, ‘pleasurable effects’ and 
‘codeine giving a buzz’  with increased tolerance to adverse effects such as withdrawals, 
medication overuse headache, nausea, constipation, tachycardia and palpitations. 
 
Continued misuse and dependence  
Adopting instrumental (behavioural and cognitive) strategies, individuals are likely to 
continue to source and use and misuse codeine leading to dependence.  
‘Addiction teaches you master manipulation. No matter what barriers you build 
an addict’s mind goes far beyond it.’ (Irish Female, 26yrs). 
 Beliefs held with conviction that ‘codeine is my helper’, ‘codeine is my companion’ and 
‘self-legitimisation’ reinforce their continued misuse and dependence. This process is further 
reinforced by pre-existing internal and external precipitating factors that predispose them to 
risk of using, misusing and dependence, and a ‘fear of stopping’.  
‘My friends are gone and it’s more a companion addiction.  It feels like it has its 
arm around you. It gives me that sense of security and that’s what I’m struggling 
with at the moment, it’s to break that cycle.’ (Irish Male, 31yrs). 
 
DISCUSSION  
Liese and Franz’s (1996) cognitive developmental model of substance abuse is applied to the 
in-depth narrative accounts of a sample of individuals experiencing codeine misuse and 
dependence. A cognitive behavioural mapping of the psychological processes involved in 
transitioning from codeine use, to misuse and toward dependence is presented. Illustrations  
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of the unique nature of these individuals’ experiences and pathways by virtue of codeine as a 
legitimately sourced OTC opiate drug despite carrying risk of habitual and dependent use, the 
accidental nature of inadvertent dependence, and interplay with various forms of physical and 
emotional pain, which ultimately creates difficulties in successful recovery. Reinforcers, 
triggers, and thoughts are influenced by the thought processes around use, the pharmacy retail 
environment, and to a lesser extent prescribing patterns.  Ultimately we sought to create 
greater understanding of codeine misuse and dependence in order to better inform the design 
of appropriate psychological treatment plans within existing OST management systems. The 
need to better understand and intervene with those requiring support for problematic codeine 
use is well evidenced in contemporary literature (Marr and Hill, 2015; Nielsen et al., 2015a; 
Nielsen et al., 2010; Pates et al., 2002).  
Reliability and validity of the qualitative research process and the application of 
findings to Liese and Franz’s (1996) cognitive developmental model of substance abuse  are 
enhanced by the trustworthiness of the data used (Lincoln and Guba, 1985), which contain 
extensive and consistent similarities in the misuse and dependence phenomenon across the 
lived experiences and social circumstances in both countries, one in the developed, and the 
other in the developing world (Van Hout, et al., 2015b; Van Hout et al., 2015d). Horizontal 
and vertical consistencies are visible in the interpretation of the codeine misuse and 
dependence phenomena, despite variance in cultural contexts, social circumstances and 
regulatory availability in each country. In terms of ‘generalisability’ both qualitative studies 
were underpinned by a constructivist approach that guided sampling, data collection and 
analysis and we do not claim that ‘generalisability’ was achieved. However, reliability of the 
data sources and validity of the model is further supported by triangulation of these 
qualitative studies, and the generated model itself against accounts of pathways to codeine 
Page 44 of 54PDF For Review
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Experiences of Codeine Use, Misuse and Dependence: Application of Liese and Franz’s Cognitive 
Developmental Model of Substance Abuse   
17 
 
misuse reported by other studies conducted in the United Kingdom (Cooper, 2011, 2013b), 
and Australia (Nielsen et al., 2010; Nielsen et al., 2011; Nielsen, Cameron and Pahoki, 2013).  
Borland (2014) advocates the need to consider how a ‘hard to maintain’ behaviour is 
maintained, whether by the skills required to perform it, reinforcement patterns, cognitive 
thought processes, environmental factors, or a multiplicity of these factors, and that such 
behaviour is often not available for conscious awareness.  Codeine misuse and dependence 
pathways appear to be maintained by the interplay between physiological determinants 
relating to pain, withdrawal and tolerance, and psychological influences. These influences 
include therapeutic need and use pre-empting of anticipated physical pain, recognition of 
appreciation of the opiate sedative therapeutic effect both for legitimate therapeutic and non-
therapeutic reasons. Iatrogenic dependence contributes to the blurring between therapeutic 
use and problematic use of codeine containing medicines. Progression toward habitual use, 
dose escalation and medication of withdrawal and anxiety related symptoms appears 
mediated by external environmental triggers pertaining to availability, and internal meta-
cognitions around physical pain and emotional distress, and the significance of the role 
codeine assumes for the user.  
Given codeine users’ unique experiences with a legitimately available opiate drug, 
lack of self-identification of habit forming use and pathways toward dependence, those 
patients do require psychological treatment interventions particular to their needs and in order 
for recovery to occur (Kean, 2015; Nielsen et al., 2011; Nielsen et al., 2015c; Van Hout, 
Delargy, Ryan, Flanagan and Gallagher, 2015a).  The recognition of iatrogenic dependence in 
these patients warrants particular psycho-social interventions alongside the management of 
pain (Hard, 2014; Marr and Hill, 2015).  Targeted psycho-social cognitive based 
interventions are warranted for this distinct group of opiate dependents (Kean, 2015; Van 
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Hout et al., 2015a;  Van Hout et al., 2015b; Van Hout et al., 2015d) and particularly those 
which target client conscious awareness of transitioning of misuse toward dependence 
(Borland, 2014; West, 2005: 2013). The model is intended to help therapists integrate 
cognitive and behaviour change strategies (for example mindfulness and acceptance), with an 
understanding of the distinct challenges for these patients in navigating pharmacies when in 
recovery, the role of trauma and distress in increasing their vulnerability, and coping 
mechanisms needed for successful rehabilitation. The role of codeine containing medicines 
appears grounded in self-regulation vulnerabilities (Khantzian, 1997; Nielsen et al., 2010). 
Cognitive conceptualisation can thus be reformulated during therapy, whilst gathering 
additional client information, experiences and evidence. Physiological, behavioural and social 
triggers, along with the interplay of anticipatory, relief-oriented, and permissive beliefs can 
contribute to relapse, even in the absence of physiological symptoms such as pain.   
 
CONCLUSION  
Psychological interventions for codeine dependence should take account of the reinforcing 
cycles of physical pain, emotional distress and codeine misuse. This model could provide 
psychological therapists working with individuals experiencing problems with codeine, 
misusing codeine and those with iatrogenic dependence with an enhanced understanding of 
the key concepts involved in these unique dependence and recovery pathways. 
 
The authors assert that all procedures contributing to this work comply with the ethical 
standards of Waterford Institute of Technology, Ireland and the South African Medical 
Research Council and with the Helsinki Declaration of 1975, and its most recent revision. 
 
The authors have no conflict of interest with respect to this publication. 
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